DPP4 and rheumatoid arthritis: Interestingly, we found that anagliptin (a dipeptidyl peptidase 4 inhibitor) also decreased the level of FABP4 in serum and synovial macrophages in an RA mouse model,53 which alleviated the severity of RA.